Wellesley, MA, United States of America

Christopher D'amato

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Fluent Biosciences Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Christopher D'amato in Single Cell Gene Profiling

Introduction

Christopher D'amato is an accomplished inventor based in Wellesley, MA. He has made significant contributions to the field of biotechnology, particularly in the area of single-cell analysis. His innovative work has the potential to advance our understanding of gene expression at the single-cell level.

Latest Patents

D'amato holds a patent for "Methods and systems for single cell gene profiling." This patent describes methods and systems for single-cell analysis, including single-cell transcriptome analysis, of target cells without the need for microfluidic devices. The disclosed methods utilize template particles to form monodisperse droplets that capture a single target cell from a population. This process allows for the derivation of distinct mRNA molecules from the single target cell, enabling the generation of an expression profile.

Career Highlights

Christopher D'amato is currently associated with Fluent Biosciences Inc., where he continues to work on innovative solutions in the field of biotechnology. His expertise in single-cell analysis has positioned him as a key player in advancing research methodologies.

Collaborations

D'amato collaborates with talented individuals such as Kristina Fontanez and Robert Meltzer, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christopher D'amato's work in single-cell gene profiling exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for new methodologies that enhance our understanding of gene expression.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…